These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 30102964

  • 1. A twenty-two-year experience with Hymenoptera venom immunotherapy in a US pediatric tertiary care center 1996-2018.
    Albuhairi S, El Khoury K, Yee C, Schneider L, Rachid R.
    Ann Allergy Asthma Immunol; 2018 Dec; 121(6):722-728.e1. PubMed ID: 30102964
    [Abstract] [Full Text] [Related]

  • 2. Exclusive Bee Venom Allergy: Risk Factors and Outcome of Immunotherapy.
    Rosman Y, Nashef F, Cohen-Engler A, Meir-Shafrir K, Lachover-Roth I, Confino-Cohen R.
    Int Arch Allergy Immunol; 2019 Dec; 180(2):128-134. PubMed ID: 31216540
    [Abstract] [Full Text] [Related]

  • 3. Venom immunotherapy for preventing allergic reactions to insect stings.
    Boyle RJ, Elremeli M, Hockenhull J, Cherry MG, Bulsara MK, Daniels M, Oude Elberink JN.
    Cochrane Database Syst Rev; 2012 Oct 17; 10(10):CD008838. PubMed ID: 23076950
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of re-sting reactions in children with moderate to severe venom hypersensitivity.
    Ertoy Karagol HI, Bakirtas A, Yilmaz O, Topal E, Arga M, Demirsoy MS, Turktas I.
    Eur J Pediatr; 2015 Jul 17; 174(7):891-6. PubMed ID: 25563216
    [Abstract] [Full Text] [Related]

  • 5. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A, Yogev A, Confino-Cohen R.
    Int Arch Allergy Immunol; 2011 Jul 17; 156(1):90-8. PubMed ID: 21447964
    [Abstract] [Full Text] [Related]

  • 6. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
    Goldberg A, Confino-Cohen R.
    J Allergy Clin Immunol; 2001 May 17; 107(5):902-6. PubMed ID: 11344360
    [Abstract] [Full Text] [Related]

  • 7. Safety and Efficacy of a Progressively Prolonged Maintenance Interval of Venom Immunotherapy.
    Kontou-Fili K, Pitsios C, Kompoti E, Giannakopoulos D, Kouridakis S.
    Int Arch Allergy Immunol; 2018 May 17; 176(1):39-43. PubMed ID: 29649812
    [Abstract] [Full Text] [Related]

  • 8. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G, Sin BA, Misirligil Z.
    J Investig Allergol Clin Immunol; 2006 May 17; 16(4):232-8. PubMed ID: 16889280
    [Abstract] [Full Text] [Related]

  • 9. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC, Pedro E, Spínola Santos A, Branco Ferreira M, Palma Carlos ML, Palma Carlos AG.
    Eur Ann Allergy Clin Immunol; 2005 Sep 17; 37(7):273-8. PubMed ID: 16285233
    [Abstract] [Full Text] [Related]

  • 10. Bee-venom allergy in children: long-term predictive value of standardized challenge tests.
    Schuetze GE, Forster J, Hauk PJ, Friedl K, Kuehr J.
    Pediatr Allergy Immunol; 2002 Feb 17; 13(1):18-23. PubMed ID: 12000494
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of hymenoptera venom immunotherapy.
    Kayikci H, Bostan OC, Tuncay G, Cihanbeylerden M, Damadoglu E, Karakaya G, Kalyoncu AF.
    Allergy Asthma Proc; 2024 Jul 01; 45(4):268-275. PubMed ID: 38982604
    [Abstract] [Full Text] [Related]

  • 12. Subcutaneous venom immunotherapy in children: Efficacy and safety.
    Gür Çetinkaya P, Esenboğa S, Uysal Soyer Ö, Tuncer A, Şekerel BE, Şahiner ÜM.
    Ann Allergy Asthma Immunol; 2018 Apr 01; 120(4):424-428. PubMed ID: 29625665
    [Abstract] [Full Text] [Related]

  • 13. Discontinuing venom immunotherapy.
    Golden DB.
    Curr Opin Allergy Clin Immunol; 2001 Aug 01; 1(4):353-6. PubMed ID: 11964712
    [Abstract] [Full Text] [Related]

  • 14. Natural history of Hymenoptera venom allergy in children not treated with immunotherapy.
    Lange J, Cichocka-Jarosz E, Marczak H, Krauze A, Tarczoń I, Świebocka E, Lis G, Brzyski P, Nowak-Węgrzyn A.
    Ann Allergy Asthma Immunol; 2016 Mar 01; 116(3):225-9. PubMed ID: 26945496
    [Abstract] [Full Text] [Related]

  • 15. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice.
    Bonifazi F, Jutel M, Biló BM, Birnbaum J, Muller U, EAACI Interest Group on Insect Venom Hypersensitivity.
    Allergy; 2005 Dec 01; 60(12):1459-70. PubMed ID: 16266376
    [Abstract] [Full Text] [Related]

  • 16. Safety profile of hymenoptera venom immunotherapy (VIT) in monosensitized patients: lack of new sensitization to nontreated insect venom.
    Spoerl D, Bircher AJ, Scherer K.
    J Investig Allergol Clin Immunol; 2011 Dec 01; 21(1):22-7. PubMed ID: 21370719
    [Abstract] [Full Text] [Related]

  • 17. Immunotherapy and biologicals for the treatment of allergy to Hymenoptera stings.
    Ridolo E, Pellicelli I, Kihlgren P, Nizi MC, Pucciarini F, Senna G, Incorvaia C.
    Expert Opin Biol Ther; 2019 Sep 01; 19(9):919-925. PubMed ID: 31190572
    [Abstract] [Full Text] [Related]

  • 18. Rush Venom Immunotherapy in Children.
    Confino-Cohen R, Rosman Y, Goldberg A.
    J Allergy Clin Immunol Pract; 2017 Sep 01; 5(3):799-803. PubMed ID: 27914814
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the Safety Profiles of 3 Different Hymenoptera Venom Immunotherapy Protocols: A Retrospective 2-Center Study of 143 Patients.
    Pospischil IM, Kagerer M, Cozzio A, Angelova-Fischer I, Guenova E, Ballmer-Weber B, Hoetzenecker W.
    Int Arch Allergy Immunol; 2020 Sep 01; 181(10):783-789. PubMed ID: 32781451
    [Abstract] [Full Text] [Related]

  • 20. Deliberate bee sting challenge of patients receiving maintenance venom immunotherapy at 3-month intervals.
    Goldberg A, Confino-Cohen R, Mekori YA.
    J Allergy Clin Immunol; 1994 Jun 01; 93(6):997-1001. PubMed ID: 8006322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.